Biomet CEO makes the case that Joint Replacements lower overall healthcare costs

JOINT-REPLACEMENT DEVICES A SOCIETAL BARGAIN (Orthopedics This Week)
We read a lot about the costs of medical technology to patient care but a closer look reveals that medical technology prices in the United States have remained consistently low for 20 years. According to Jeffrey R. Binder, president and CEO of Biomet Inc. and a member of the board of directors at the Advanced Medical Technology Association, writing for the online publication Phily.com, medical technology prices have grown at about an average annual rate of 1%—half the rate of prices in the overall economy.
Binder writes that ...